APO Research
Talk to an analyst

APO RESEARCH · REPORT

Animal Blood Plasma Products and Derivatives

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Animal Blood Plasma Products and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchAnimal Blood Plasma Products and Derivatives Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Animal Blood Plasma Products and Derivatives Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Animal Blood Plasma Products and Derivatives Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Animal Blood Plasma Products and Derivatives Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Animal Blood Plasma Products and Derivatives Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Animal Blood Plasma Products and Derivatives market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Animal Blood Plasma Products and Derivatives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Animal Blood Plasma Products and Derivatives include Thermo Fisher Scientific, Sigma-Aldrich, Rocky Mountain Biologicals, Proliant, LAMPIRE Biological Laboratories, Lake Immunogenics, Kraeber & Co. GmbH, Bovogen Biologicals and Auckland BioSciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Animal Blood Plasma Products and Derivatives market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Animal Blood Plasma Products and Derivatives and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Animal Blood Plasma Products and Derivatives sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Animal Blood Plasma Products and Derivatives market size, projected growth trends, production technologies, key applications, and end-use industries.

Animal Blood Plasma Products and Derivatives Segment by Company

Thermo Fisher Scientific

Sigma-Aldrich

Rocky Mountain Biologicals

Proliant

LAMPIRE Biological Laboratories

Lake Immunogenics

Kraeber & Co. GmbH

Bovogen Biologicals

Auckland BioSciences

ANZCO Foods

Animal Blood Plasma Products and Derivatives Segment by Type

Serum Albumin

Fibrinogen

Fetal Bovine Serum

Immunoglobulin

Animal Blood Plasma Products and Derivatives Segment by Application

Pharmaceutical Industry

Diagnostic Industry

Sports Nutrition

Nutrition Supplements

Cell Culture Media

Food Industry

Cosmetic Industry

Pet Food Industry

Animal Blood Plasma Products and Derivatives Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Blood Plasma Products and Derivatives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Animal Blood Plasma Products and Derivatives and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Blood Plasma Products and Derivatives.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Animal Blood Plasma Products and Derivatives market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Animal Blood Plasma Products and Derivatives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Animal Blood Plasma Products and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Animal Blood Plasma Products and Derivatives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Animal Blood Plasma Products and Derivatives Industry Trends Table 2. Animal Blood Plasma Products and Derivatives Industry Drivers Table 3. Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges Table 4. Animal Blood Plasma Products and Derivatives Industry Restraints Table 5. Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Animal Blood Plasma Products and Derivatives Sales by Manufacturers (tons) & (2021-2026) Table 8. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers Table 9. Global Animal Blood Plasma Products and Derivatives Average Sales Price (US$/kg) of Manufacturers (2021-2026) Table 10. Global Animal Blood Plasma Products and Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Animal Blood Plasma Products and Derivatives Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Animal Blood Plasma Products and Derivatives Manufacturers, Product Type & Application Table 13. Global Animal Blood Plasma Products and Derivatives Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Animal Blood Plasma Products and Derivatives by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Serum Albumin Table 17. Major Manufacturers of Fibrinogen Table 18. Major Manufacturers of Fetal Bovine Serum Table 19. Major Manufacturers of Immunoglobulin Table 20. Global Animal Blood Plasma Products and Derivatives Sales by Type 2021 VS 2025 VS 2032 (tons) Table 21. Global Animal Blood Plasma Products and Derivatives Sales by Type (2021-2026) & (tons) Table 22. Global Animal Blood Plasma Products and Derivatives Sales by Type (2027-2032) & (tons) Table 23. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2021-2026) Table 24. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2027-2032) Table 25. Global Animal Blood Plasma Products and Derivatives Revenue by Type 2021 VS 2025 VS 2032 (tons) Table 26. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2026) & (tons) Table 27. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2027-2032) & (tons) Table 28. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2021-2026) Table 29. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceutical Industry Table 31. Major Manufacturers of Diagnostic Industry Table 32. Major Manufacturers of Sports Nutrition Table 33. Major Manufacturers of Nutrition Supplements Table 34. Major Manufacturers of Cell Culture Media Table 35. Major Manufacturers of Food Industry Table 36. Major Manufacturers of Cosmetic Industry Table 37. Major Manufacturers of Pet Food Industry Table 38. Global Animal Blood Plasma Products and Derivatives Sales by Application 2021 VS 2025 VS 2032 (tons) Table 39. Global Animal Blood Plasma Products and Derivatives Sales by Application (2021-2026) & (tons) Table 40. Global Animal Blood Plasma Products and Derivatives Sales by Application (2027-2032) & (tons) Table 41. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2021-2026) Table 42. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2027-2032) Table 43. Global Animal Blood Plasma Products and Derivatives Revenue by Application 2021 VS 2025 VS 2032 (tons) Table 44. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2026) & (tons) Table 45. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2027-2032) & (tons) Table 46. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2021-2026) Table 47. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2027-2032) Table 48. Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 49. Global Animal Blood Plasma Products and Derivatives Sales by Region (2021-2026) & (tons) Table 50. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2021-2026) Table 51. Global Animal Blood Plasma Products and Derivatives Sales Forecasted by Region (2027-2032) & (tons) Table 52. Global Animal Blood Plasma Products and Derivatives Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 54. North America Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 55. North America Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 56. Europe Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 57. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 58. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 59. Asia Pacific Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 60. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 61. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 62. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (tons) Table 63. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2021-2026) & (tons) Table 64. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2027-2032) & (tons) Table 65. Global Animal Blood Plasma Products and Derivatives Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2021-2026) Table 69. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2027-2032) Table 70. Thermo Fisher Scientific Company Information Table 71. Thermo Fisher Scientific Business Overview Table 72. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio Table 74. Thermo Fisher Scientific Recent Development Table 75. Sigma-Aldrich Company Information Table 76. Sigma-Aldrich Business Overview Table 77. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio Table 79. Sigma-Aldrich Recent Development Table 80. Rocky Mountain Biologicals Company Information Table 81. Rocky Mountain Biologicals Business Overview Table 82. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio Table 84. Rocky Mountain Biologicals Recent Development Table 85. Proliant Company Information Table 86. Proliant Business Overview Table 87. Proliant Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Proliant Animal Blood Plasma Products and Derivatives Product Portfolio Table 89. Proliant Recent Development Table 90. LAMPIRE Biological Laboratories Company Information Table 91. LAMPIRE Biological Laboratories Business Overview Table 92. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio Table 94. LAMPIRE Biological Laboratories Recent Development Table 95. Lake Immunogenics Company Information Table 96. Lake Immunogenics Business Overview Table 97. Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio Table 99. Lake Immunogenics Recent Development Table 100. Kraeber & Co. GmbH Company Information Table 101. Kraeber & Co. GmbH Business Overview Table 102. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio Table 104. Kraeber & Co. GmbH Recent Development Table 105. Bovogen Biologicals Company Information Table 106. Bovogen Biologicals Business Overview Table 107. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio Table 109. Bovogen Biologicals Recent Development Table 110. Auckland BioSciences Company Information Table 111. Auckland BioSciences Business Overview Table 112. Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio Table 114. Auckland BioSciences Recent Development Table 115. ANZCO Foods Company Information Table 116. ANZCO Foods Business Overview Table 117. ANZCO Foods Animal Blood Plasma Products and Derivatives Sales (tons), Price (US$/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio Table 119. ANZCO Foods Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. Animal Blood Plasma Products and Derivatives Distributors List Table 123. Animal Blood Plasma Products and Derivatives Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. Animal Blood Plasma Products and Derivatives Product Image Figure 2. Global Animal Blood Plasma Products and Derivatives Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Animal Blood Plasma Products and Derivatives Market Size (2021-2032) & (US$ Million) Figure 4. Global Animal Blood Plasma Products and Derivatives Sales (2021-2032) & (tons) Figure 5. Global Animal Blood Plasma Products and Derivatives Average Price (US$/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Animal Blood Plasma Products and Derivatives Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Serum Albumin Image Figure 9. Fibrinogen Image Figure 10. Fetal Bovine Serum Image Figure 11. Immunoglobulin Image Figure 12. Global Animal Blood Plasma Products and Derivatives Sales by Type (2021 VS 2025 VS 2032) & (tons) Figure 13. Global Animal Blood Plasma Products and Derivatives Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2021-2032) Figure 15. Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021 VS 2025 VS 2032) & (tons) Figure 16. Global Animal Blood Plasma Products and Derivatives Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceutical Industry Image Figure 19. Diagnostic Industry Image Figure 20. Sports Nutrition Image Figure 21. Nutrition Supplements Image Figure 22. Cell Culture Media Image Figure 23. Food Industry Image Figure 24. Cosmetic Industry Image Figure 25. Pet Food Industry Image Figure 26. Global Animal Blood Plasma Products and Derivatives Sales by Application (2021 VS 2025 VS 2032) & (tons) Figure 27. Global Animal Blood Plasma Products and Derivatives Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2021-2032) Figure 29. Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021 VS 2025 VS 2032) & (tons) Figure 30. Global Animal Blood Plasma Products and Derivatives Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2021-2032) Figure 32. North America Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 33. North America Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2021-2032) Figure 34. U.S. Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 35. Canada Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 36. Mexico Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 37. Europe Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 38. Europe Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2021-2032) Figure 39. Germany Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 40. France Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 41. U.K. Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 42. Italy Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 43. Netherlands Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 44. Asia Pacific Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 45. Asia Pacific Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2021-2032) Figure 46. China Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 47. Japan Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 48. South Korea Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 49. Southeast Asia Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 50. India Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 51. Australia Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 52. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 53. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2021-2032) Figure 54. Brazil Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 55. South Africa Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 56. Saudi Arabia Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 57. Turkey Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 58. Argentina Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 59. UAE Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 60. Egypt Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 61. Chile Animal Blood Plasma Products and Derivatives Sales and Growth Rate (2021-2032) & (tons) Figure 62. Global Animal Blood Plasma Products and Derivatives Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Figure 65. North America Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Figure 67. Europe Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Animal Blood Plasma Products and Derivatives Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Animal Blood Plasma Products and Derivatives Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Serum Albumin
  • Fibrinogen
  • Fetal Bovine Serum
  • Immunoglobulin
Applications
  • Pharmaceutical Industry
  • Diagnostic Industry
  • Sports Nutrition
  • Nutrition Supplements
  • Cell Culture Media
  • Food Industry
  • Cosmetic Industry
  • Pet Food Industry
Companies covered
  • Thermo Fisher Scientific
  • Sigma-Aldrich
  • Rocky Mountain Biologicals
  • Proliant
  • LAMPIRE Biological Laboratories
  • Lake Immunogenics
  • Kraeber & Co. GmbH
  • Bovogen Biologicals
  • Auckland BioSciences
  • ANZCO Foods

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Animal Blood Plasma Products and Derivatives Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Animal Blood Plasma Products and Derivatives Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Animal Blood Plasma Products and Derivatives Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Animal Blood Plasma Products and Derivatives Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Animal Blood Plasma Products and Derivatives Market Dynamics
  1. 2.1 Animal Blood Plasma Products and Derivatives Industry Trends
  2. 2.2 Animal Blood Plasma Products and Derivatives Industry Drivers
  3. 2.3 Animal Blood Plasma Products and Derivatives Industry Opportunities and Challenges
  4. 2.4 Animal Blood Plasma Products and Derivatives Industry Restraints
3 Animal Blood Plasma Products and Derivatives Market by Manufacturers
  1. 3.1 Global Animal Blood Plasma Products and Derivatives Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Animal Blood Plasma Products and Derivatives Sales by Manufacturers (2021-2026)
  3. 3.3 Global Animal Blood Plasma Products and Derivatives Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Animal Blood Plasma Products and Derivatives Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Animal Blood Plasma Products and Derivatives Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Animal Blood Plasma Products and Derivatives Manufacturers, Product Type & Application
  7. 3.7 Global Animal Blood Plasma Products and Derivatives Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Animal Blood Plasma Products and Derivatives Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Animal Blood Plasma Products and Derivatives Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Animal Blood Plasma Products and Derivatives Tier 1, Tier 2, and Tier 3
4 Animal Blood Plasma Products and Derivatives Market by Type
  1. 4.1 Animal Blood Plasma Products and Derivatives Type Introduction
  2. 4.1.1 Serum Albumin
  3. 4.1.2 Fibrinogen
  4. 4.1.3 Fetal Bovine Serum
  5. 4.1.4 Immunoglobulin
  6. 4.2 Global Animal Blood Plasma Products and Derivatives Sales by Type
  7. 4.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Animal Blood Plasma Products and Derivatives Sales by Type (2021-2032)
  9. 4.2.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2021-2032)
  10. 4.3 Global Animal Blood Plasma Products and Derivatives Revenue by Type
  11. 4.3.1 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2021-2032)
  13. 4.3.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2021-2032)
5 Animal Blood Plasma Products and Derivatives Market by Application
  1. 5.1 Animal Blood Plasma Products and Derivatives Application Introduction
  2. 5.1.1 Pharmaceutical Industry
  3. 5.1.2 Diagnostic Industry
  4. 5.1.3 Sports Nutrition
  5. 5.1.4 Nutrition Supplements
  6. 5.1.5 Cell Culture Media
  7. 5.1.6 Food Industry
  8. 5.1.7 Cosmetic Industry
  9. 5.1.8 Pet Food Industry
  10. 5.2 Global Animal Blood Plasma Products and Derivatives Sales by Application
  11. 5.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Application (2021 VS 2025 VS 2032)
  12. 5.2.2 Global Animal Blood Plasma Products and Derivatives Sales by Application (2021-2032)
  13. 5.2.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2021-2032)
  14. 5.3 Global Animal Blood Plasma Products and Derivatives Revenue by Application
  15. 5.3.1 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021 VS 2025 VS 2032)
  16. 5.3.2 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2021-2032)
  17. 5.3.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2021-2032)
6 Global Animal Blood Plasma Products and Derivatives Sales by Region
  1. 6.1 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Animal Blood Plasma Products and Derivatives Sales by Region (2021-2032)
  3. 6.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Region (2021-2026)
  4. 6.2.2 Global Animal Blood Plasma Products and Derivatives Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Animal Blood Plasma Products and Derivatives Revenue by Region
  1. 7.1 Global Animal Blood Plasma Products and Derivatives Revenue by Region
  2. 7.1.1 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Animal Blood Plasma Products and Derivatives Revenue by Region (2021-2026)
  4. 7.1.3 Global Animal Blood Plasma Products and Derivatives Revenue by Region (2027-2032)
  5. 7.1.4 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Animal Blood Plasma Products and Derivatives Revenue (2021-2032)
  8. 7.2.2 North America Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Animal Blood Plasma Products and Derivatives Revenue (2021-2032)
  11. 7.3.2 Europe Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Sigma-Aldrich
  8. 8.2.1 Sigma-Aldrich Company Information
  9. 8.2.2 Sigma-Aldrich Business Overview
  10. 8.2.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio
  12. 8.2.5 Sigma-Aldrich Recent Developments
  13. 8.3 Rocky Mountain Biologicals
  14. 8.3.1 Rocky Mountain Biologicals Company Information
  15. 8.3.2 Rocky Mountain Biologicals Business Overview
  16. 8.3.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
  18. 8.3.5 Rocky Mountain Biologicals Recent Developments
  19. 8.4 Proliant
  20. 8.4.1 Proliant Company Information
  21. 8.4.2 Proliant Business Overview
  22. 8.4.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Proliant Animal Blood Plasma Products and Derivatives Product Portfolio
  24. 8.4.5 Proliant Recent Developments
  25. 8.5 LAMPIRE Biological Laboratories
  26. 8.5.1 LAMPIRE Biological Laboratories Company Information
  27. 8.5.2 LAMPIRE Biological Laboratories Business Overview
  28. 8.5.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio
  30. 8.5.5 LAMPIRE Biological Laboratories Recent Developments
  31. 8.6 Lake Immunogenics
  32. 8.6.1 Lake Immunogenics Company Information
  33. 8.6.2 Lake Immunogenics Business Overview
  34. 8.6.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio
  36. 8.6.5 Lake Immunogenics Recent Developments
  37. 8.7 Kraeber & Co. GmbH
  38. 8.7.1 Kraeber & Co. GmbH Company Information
  39. 8.7.2 Kraeber & Co. GmbH Business Overview
  40. 8.7.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio
  42. 8.7.5 Kraeber & Co. GmbH Recent Developments
  43. 8.8 Bovogen Biologicals
  44. 8.8.1 Bovogen Biologicals Company Information
  45. 8.8.2 Bovogen Biologicals Business Overview
  46. 8.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
  48. 8.8.5 Bovogen Biologicals Recent Developments
  49. 8.9 Auckland BioSciences
  50. 8.9.1 Auckland BioSciences Company Information
  51. 8.9.2 Auckland BioSciences Business Overview
  52. 8.9.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio
  54. 8.9.5 Auckland BioSciences Recent Developments
  55. 8.10 ANZCO Foods
  56. 8.10.1 ANZCO Foods Company Information
  57. 8.10.2 ANZCO Foods Business Overview
  58. 8.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio
  60. 8.10.5 ANZCO Foods Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Animal Blood Plasma Products and Derivatives Value Chain Analysis
  2. 9.1.1 Animal Blood Plasma Products and Derivatives Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Animal Blood Plasma Products and Derivatives Production Mode & Process
  6. 9.2 Animal Blood Plasma Products and Derivatives Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Animal Blood Plasma Products and Derivatives Distributors
  9. 9.2.3 Animal Blood Plasma Products and Derivatives Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst